M. García

Fibroblast activation and abnormal extracellular matrix remodelling as common hallmarks in three cancer‐prone genodermatoses

S. Puig, J. Dopazo, S. Llames, 2019, The British journal of dermatology.

Mechanistic interrogation of mutation-independent disease modulators of RDEB identifies the small leucine-rich proteoglycan PRELP as a TGF-β antagonist and inhibitor of fibrosis.

M. del Río, F. Larcher, M. Escámez, 2022, Matrix biology : journal of the International Society for Matrix Biology.

Recessive dystrophic epidermolysis bullosa: the origin of the c.6527insC mutation in the Spanish population

E. Aller, M. del Río, C. Ayuso, 2013, The British journal of dermatology.

X-Linked Ichthyosis along with Recessive Dystrophic Epidermolysis Bullosa in the Same Patient

M. del Río, R. González-Sarmiento, A. Torrelo, 2010, Dermatology.

Skin gene therapy for acquired and inherited disorders.

O. Podhajcer, M. del Río, F. Larcher, 2006, Histology and histopathology.

Improving flap survival by transplantation of a VEGF-secreting endothelised scaffold during distal pedicle flap creation.

M. Muñoz-Fernández, J. Lasso, M. D. del Río, 2007, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

Two novel recessive mutations in KRT14 identified in a cohort of 21 Spanish families with epidermolysis bullosa simplex

S. Llames, M. del Río, D. Mechan, 2011, The British journal of dermatology.

A Recurrent Nonsense Mutation Occurring as a de novo Event in a Patient with Recessive Dystrophic Epidermolysis Bullosa

M. del Río, C. Conti, G. Zambruno, 2011, Dermatology.

The first COL7A1 mutation survey in a large Spanish dystrophic epidermolysis bullosa cohort: c.6527insC disclosed as an unusually recurrent mutation

S. Llames, M. del Río, F. Larcher, 2010, The British journal of dermatology.

Fibroblasts activation and abnormal extracellular matrix remodelling as common hallmarks in three cancer-prone genodermatoses

S. Llames, F. Larcher, F. García-García, 2019 .